agents affecting blood constituents. Other and unspecified agents affecting blood constituents
Conditions
Interventions
Intervention 1: garlic 1250mg one tablet a day for 30 days. Intervention 2: garlic(1250mg) 2 tablets a day for 30 days. Intervention 3: 3 tablets(1250 mg) garlic a day for 30 days.
Treatment - Drugs
garlic 1250mg one tablet a day for 30 days
garlic(1250mg) 2 tablets a day for 30 days
3 tablets(1250 mg) garlic a day for 30 days
Sponsors
Pharmaceutical Siences Reseaserch
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Exclusion criteria applied to individuals who had cardiovascular disease, been using aspirin, clopidogrel and nonsteroidal anti inflammatory drugs ( NSAIDS) in the last 2 weeks ago , thrombocytopenia(platelet<100 × 10 3 platelets /mm3 ), anemia(hemoglobin<10g/dl),abnormal lipid profile[total chlosterol = 200 mg/dl , LDL-C =100mg/dl , TG = 200 mg/dl HDL= 45 mg/dl(male) and = 55 mg/dl(female) ], Diabetes mellitus (FBS = 126 mg/ dl confirmed by repeating the test), and renal failure[Serum creatinine = 2mg/dl (female) and Serum creatinine=2.5 mg/dl (male)] inclusion criteria : 62 healthy individuals(non diabetic ? normal lipid profile ? without any cardiovascular disease and coagulation disordes ?non used aspirin, clopidogrel and nonsteroidal anti inflammatory drugs ( NSAIDS) in the last 2 weeks ago aged 20-50 years old were enrolled in this clinical trial.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Platelet aggregation. Timepoint: 3 months. Method of measurement: Light transmission aggregometer. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMojtaba Shafikhani
Shiraz University Of Medical Sciences
Outcome results
None listed